AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767E902. A total of 3 filers reported holding AEGERION PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $16,000 | -69.8% | 10,900 | -23.2% | 0.00% | – |
| Q1 2016 | $53,000 | -78.7% | 14,200 | -42.5% | 0.00% | – |
| Q4 2015 | $249,000 | -12.3% | 24,700 | +18.2% | 0.00% | – |
| Q3 2015 | $284,000 | -51.7% | 20,900 | -32.6% | 0.00% | -100.0% |
| Q2 2015 | $588,000 | -15.5% | 31,000 | +16.5% | 0.00% | 0.0% |
| Q1 2015 | $696,000 | -25.6% | 26,600 | -40.5% | 0.00% | 0.0% |
| Q4 2014 | $936,000 | -68.0% | 44,700 | -48.9% | 0.00% | -66.7% |
| Q3 2014 | $2,921,000 | +93.7% | 87,500 | +86.2% | 0.00% | +50.0% |
| Q2 2014 | $1,508,000 | -43.3% | 47,000 | -18.5% | 0.00% | -33.3% |
| Q1 2014 | $2,661,000 | +0.3% | 57,700 | +54.3% | 0.00% | 0.0% |
| Q4 2013 | $2,654,000 | -1.4% | 37,400 | +19.1% | 0.00% | -25.0% |
| Q3 2013 | $2,691,000 | +8.6% | 31,400 | -19.7% | 0.00% | 0.0% |
| Q2 2013 | $2,477,000 | – | 39,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 45,000 | $1,502,000 | 0.02% |
| PEAK6 Group LLC | 29,200 | $975,000 | 0.01% |
| Citadel Advisors | 87,500 | $2,921,000 | 0.00% |